title: Role of the investigator in phase 1 trials of anticancer drugs.
authors.affiliation: Centre Oscar Lambret, 3 rue Frédéric Combemale, 59020 Lille, France. n-penel@o-lambret.fr
authors.forename: Nicolas
authors.initials: N
authors.lastname: Penel
authors.forename: Antoine
authors.initials: A
authors.lastname: Adenis
authors.forename: Jacques
authors.initials: J
authors.lastname: Bonneterre
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D066246:ErbB Receptors / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D066246:ErbB Receptors